C. R. Meier, “Pharmacoepidemiology – Assessing the Risks and Benefits of Drugs in the Postmarketing Phase”, Chimia, vol. 60, no. 1-2, p. 54, Feb. 2006, doi: 10.2533/000942906777675272.